http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022001014-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4859db02a380a9d625ebe5a35ff1d002 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate | 2021-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8511d61ab92a1d134614fbff74500efc |
| publicationDate | 2022-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2022001014-A1 |
| titleOfInvention | Compositions and methods for inducing biological mimicry in a mammal for the prevention and/or treatment of covid-19 and other diseases |
| abstract | The present invention is directed to compositions and methods for inducing artificial biological mimicry in a mammal to mimic the favorable immune advantages present in a bat in another mammal, particularly a human subject, and thereby prevent and/or treat COVID-19 and other diseases by administering to the subject a combination of active agents comprising two or more active agents comprising an inhibitor of inflammasome NLRP3, an inhibitor of one or more priming or activation signals of inflammasome NLRP3, and/or an activator of the inhibitor of one or more priming or activation signals of inflammasome NLRP3 alone or in combination with one or more modulators of Kallikrein-Kinin System (KKS) dysregulation, one or more modulators of Renin Aldosterone Angiotensin System (RAAS) dysregulation, one or more modulators of protease dysregulation, and/or one or more modulators of cytokine dysregulation. Pharmaceutical compositions, methods of treatment, methods of genetic testing, and packaged kits are provided. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115089713-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115414364-A |
| priorityDate | 2020-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1220.